Please try another search
AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
Name | Age | Since | Title |
---|---|---|---|
Louis James Panaccio | 64 | 2014 | Independent Non-Executive Chairman |
Fiona Melanie Wood | - | 2006 | Founder and Member of Clinical Advisory Board |
Suzanne Crowe | 73 | 2016 | Independent Non-Executive Director |
Jeremy L. Curnock-Cook | 74 | 2012 | Independent Non-Executive Director |
James M. Corbett | 66 | 2021 | CEO, President & Executive Director |
Cary G. Vance | 58 | 2023 | Independent Non-Executive Director |
Jan Stern Reed | 64 | 2021 | Independent Non-Executive Director |
Robert E. McNamara | 67 | 2023 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review